The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research letter published online April 8 in the Annals of Internal Medicine.
TUESDAY, April 15, 2025 — After approval, tirzepatide dispensations increased markedly among adults with type 2 diabetes prescribed glucose-lowering medications (GLMs) and among adults without diabetes prescribed weight-lowering medications (WLMs)…
TUESDAY, April 15, 2025 — The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research letter published online April 8 in the…
(MedPage Today) — Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to share your story, please email MPT_Editorial…
Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide are increasingly used to promote weight loss, working in part by modulating the part of the brain responsible for hunger. Given this mechanism, researchers have wondered if and how GLP-1 medications could affect cravings for addictive substances such as alcohol.
The FDA on Monday urged patients and doctors to check that their Ozempic prescriptions are legitimate after the agency seized several hundred fake units of the diabetes drug.
Audience: Consumers April 14, 2025 — FDA was notified by Novo Nordisk on April 3, 2025, that several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg were in the U.S. drug supply chain. The counterfeit products were distributed…
Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a patient participating in a trial.Read more…
Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years in adults with overweight or obesity who do not have diabetes, according to new research being presented at the European Congress on Obesity (ECO) in Malaga, Spain (11–14 May).
PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ — Novo Nordisk has become aware of several hundred units of Ozempic (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized supply chain in the US. The US Food and Drug…